Afsaneh Shirani

18PUBLICATIONS
10CO-AUTHORS
Metabolic medicineMortalityTumour immunologyMedical biotechnology diagnostics (incl. biosensors)Gender, policy and administration
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 09, 2026
Evolving MS criteria and the interpretation of research.

|Jul 06, 2026
The delayed morbidity of war.

|Feb 23, 2026
Vedolizumab and the gut-CNS axis in multiple sclerosis: considering T cell licensing pathways.

Afsaneh Shirani, Olaf Stuve

|Jan 09, 2026
Beyond BMI: incorporating new obesity definitions to guide MS risk stratification.

Afsaneh Shirani, Anne Cross

|Jan 06, 2026
Rethinking Long-Term Leadership in Academia: Lessons from Presidential Term Limits.

Afsaneh Shirani

|Nov 21, 2025
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System.

Afsaneh Shirani, Samuel A Goldlust, Olaf Stuve

Pageof 3